EYPT

$0.00

(

+0.00%

)
Quote details

stock

Eyepoint Pharmaceuticals Inc

NASDAQ | EYPT

14.29

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$1.18B

Market Cap

-

P/E Ratio

-3

EPS

$14.96

52 Week High

$3.91

52 Week Low

HEALTHCARE

Sector

EYPT Chart

Recent Chart
Price Action

EYPT Technicals

Tags:

EYPT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.7M
Costof Goods And Services Sold $3.7M
Operating Income -$146M
Selling General And Administrative $52M
Research And Development $133M
Operating Expenses $185M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.5M
Income Before Tax -$131M
Income Tax Expense $90K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$131M
Ebitda -$129M
Net Income -$131M

Revenue & Profitability

Earnings Performance

EYPT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $418M
Total Current Assets $383M
Cash And Cash Equivalents At Carrying Value $100M
Cash And Short Term Investments $100M
Inventory $2.3M
Current Net Receivables $607K
Total Non Current Assets $35M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $271M
Other Current Assets $9.5M
Other Non Current Assets -
Total Liabilities $82M
Total Current Liabilities $49M
Current Accounts Payable $12M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $33M
Capital Lease Obligations $22M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $22M
Other Current Liabilities $20M
Other Non Current Liabilities $205K
Total Shareholder Equity $337M
Treasury Stock -
Retained Earnings -$873M
Common Stock $68K
Common Stock Shares Outstanding $56M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$126M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.5M
Capital Expenditures $4.1M
Change In Receivables -
Change In Inventory $1.6M
Profit Loss -
Cashflow From Investment -$219M
Cashflow From Financing $164M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$131M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $43M
Cost Of Revenue $3.7M
Costof Goods And Services Sold $3.7M
Operating Income -$146M
Selling General And Administrative $52M
Research And Development $133M
Operating Expenses $185M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.5M
Income Before Tax -$131M
Income Tax Expense $90K
Interest And Debt Expense -
Net Income From Continuing Operations -$131M
Comprehensive Income Net Of Tax -
Ebit -$131M
Ebitda -$129M
Net Income -$131M

EYPT News

EYPT Profile

Eyepoint Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

EyePoint Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Watertown, Massachusetts, dedicated to developing innovative therapeutics for serious ocular diseases. Utilizing its proprietary micro-insert technology, the company specializes in sustained-release drug delivery systems designed to meet significant unmet medical needs in ophthalmology. With a robust pipeline targeting conditions such as retinal diseases, EyePoint is strategically poised for growth in major markets, including the United States, China, and the United Kingdom, establishing itself as a critical contributor in the advancing field of eye care.

LPTX
+368.57%
$2.05
VRAX
+69.66%
$0.66
PAVS
-34.48%
$0.03
VHAI
0.00%
$0.00
IXHL
+6.40%
$0.42
FTEL
-0.83%
$1.19
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
IRBT
+46.15%
$2.85
BBD
+1.38%
$3.67
NVDA
-0.27%
$180.95
ONDS
-3.71%
$7.77
ADAP
-15.14%
$0.05
MARA
+3.38%
$11.91
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
SOND
-23.45%
$0.12
NIO
-4.61%
$4.79
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
QCLS
+23.07%
$4.16
ITUB
+2.64%
$7.89
SRM
+53.27%
$10.30
BYND
-5.03%
$1.22
INTC
+0.01%
$43.47
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
BURU
-0.76%
$0.21
INHD
-9.17%
$0.13
WLGS
-5.57%
$0.04
ASST
-0.96%
$1.02
MTSR
-0.35%
$70.50
RR
+6.74%
$3.80
BMNU
+10.01%
$8.07
NFLX
+0.20%
$109.35
CAPR
+314.93%
$26.39
BITF
-2.05%
$3.03
AFMD
-34.94%
$0.18
IREN
+2.42%
$42.11
IMRN
-5.45%
$1.64
LUMN
+10.25%
$9.14
PMAX
+24.61%
$2.82
AMCR
-1.63%
$8.40
MSFT
+0.66%
$490.00
MRVL
+6.12%
$98.58
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
HTOO
+15.80%
$4.05
PLTZ
-3.85%
$6.99
CRCL
+1.97%
$77.44
SOFI
+0.86%
$29.76
BMNR
+7.01%
$34.15
CMND
-20.37%
$0.10
PLUG
+1.42%
$2.14
KDLY
-2.95%
$0.48
CHR
-7.42%
$0.03
AAL
+0.87%
$14.36
SAND
-6.04%
$12.12
CDE
-2.41%
$16.55
QBTS
+5.02%
$23.63
AUR
0.00%
$3.99
SHOT
-74.37%
$0.39
VIVK
-6.01%
$0.10
ZAPP
-46.30%
$0.15
NCLH
-0.75%
$18.43
ASBP
-9.00%
$0.09
ARTL
-2.77%
$1.75
KXIN
+30.48%
$4.04
AAPL
+0.03%
$286.29
GUTS
+17.94%
$1.84
CIFR
+0.73%
$17.77
AMD
+1.25%
$217.95
ALIT
-5.50%
$2.23
WULF
-2.26%
$13.89
CPNG
+0.22%
$26.71
AEO
+15.38%
$24.03
GTLB
-14.28%
$37.17
PLTR
+1.44%
$173.15
AMZN
-0.75%
$232.65
PSTG
+6.96%
$94.72
BMY
+4.19%
$50.27
SONN
-59.35%
$1.26
F
+0.73%
$13.05
PFSA
+9.92%
$0.17
YGMZ
-12.76%
$0.07
FTRK
+14.28%
$0.44
ASAN
+4.85%
$13.39
PRMB
-0.48%
$16.33
GOOGL
+0.47%
$317.30
HOOD
+3.51%
$130.38
GM
+0.97%
$73.66
TLRY
-1.45%
$7.71
TEVA
+0.59%
$26.88
APH
+1.63%
$141.49
ACHR
+3.00%
$7.88
M
-1.21%
$22.43
CLSK
+1.09%
$13.86
LPTX
+368.57%
$2.05
VRAX
+69.66%
$0.66
PAVS
-34.48%
$0.03
VHAI
0.00%
$0.00
IXHL
+6.40%
$0.42
FTEL
-0.83%
$1.19
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
TSLA
-0.20%
$429.24
AXDX
-61.36%
$0.03
IRBT
+46.15%
$2.85
BBD
+1.38%
$3.67
NVDA
-0.27%
$180.95
ONDS
-3.71%
$7.77
ADAP
-15.14%
$0.05
MARA
+3.38%
$11.91
DNN
+2.77%
$2.59
PFE
-0.47%
$25.15
SOND
-23.45%
$0.12
NIO
-4.61%
$4.79
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
QCLS
+23.07%
$4.16
ITUB
+2.64%
$7.89
SRM
+53.27%
$10.30
BYND
-5.03%
$1.22
INTC
+0.01%
$43.47
PLTD
-1.83%
$6.96
VALE
+1.57%
$12.89
BURU
-0.76%
$0.21
INHD
-9.17%
$0.13
WLGS
-5.57%
$0.04
ASST
-0.96%
$1.02
MTSR
-0.35%
$70.50
RR
+6.74%
$3.80
BMNU
+10.01%
$8.07
NFLX
+0.20%
$109.35
CAPR
+314.93%
$26.39
BITF
-2.05%
$3.03
AFMD
-34.94%
$0.18
IREN
+2.42%
$42.11
IMRN
-5.45%
$1.64
LUMN
+10.25%
$9.14
PMAX
+24.61%
$2.82
AMCR
-1.63%
$8.40
MSFT
+0.66%
$490.00
MRVL
+6.12%
$98.58
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
HTOO
+15.80%
$4.05
PLTZ
-3.85%
$6.99
CRCL
+1.97%
$77.44
SOFI
+0.86%
$29.76
BMNR
+7.01%
$34.15
CMND
-20.37%
$0.10
PLUG
+1.42%
$2.14
KDLY
-2.95%
$0.48
CHR
-7.42%
$0.03
AAL
+0.87%
$14.36
SAND
-6.04%
$12.12
CDE
-2.41%
$16.55
QBTS
+5.02%
$23.63
AUR
0.00%
$3.99
SHOT
-74.37%
$0.39
VIVK
-6.01%
$0.10
ZAPP
-46.30%
$0.15
NCLH
-0.75%
$18.43
ASBP
-9.00%
$0.09
ARTL
-2.77%
$1.75
KXIN
+30.48%
$4.04
AAPL
+0.03%
$286.29
GUTS
+17.94%
$1.84
CIFR
+0.73%
$17.77
AMD
+1.25%
$217.95
ALIT
-5.50%
$2.23
WULF
-2.26%
$13.89
CPNG
+0.22%
$26.71
AEO
+15.38%
$24.03
GTLB
-14.28%
$37.17
PLTR
+1.44%
$173.15
AMZN
-0.75%
$232.65
PSTG
+6.96%
$94.72
BMY
+4.19%
$50.27
SONN
-59.35%
$1.26
F
+0.73%
$13.05
PFSA
+9.92%
$0.17
YGMZ
-12.76%
$0.07
FTRK
+14.28%
$0.44
ASAN
+4.85%
$13.39
PRMB
-0.48%
$16.33
GOOGL
+0.47%
$317.30
HOOD
+3.51%
$130.38
GM
+0.97%
$73.66
TLRY
-1.45%
$7.71
TEVA
+0.59%
$26.88
APH
+1.63%
$141.49
ACHR
+3.00%
$7.88
M
-1.21%
$22.43
CLSK
+1.09%
$13.86

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.